Stock Scorecard



Stock Summary for Agilon Health Inc (AGL) - $5.73 as of 3/28/2024 12:13:27 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AGL

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AGL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AGL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for AGL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for AGL

AGL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that agilon health, inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Agilon Health ( NYSE:AGL ) 3/28/2024 2:00:00 PM
AGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health, inc. - AGL - Agilon Health ( NYSE:AGL ) 3/28/2024 2:47:00 AM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGL - Agilon Health ( NYSE:AGL ) 3/27/2024 8:11:00 PM
AGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health, inc. - AGL - Agilon Health ( NYSE:AGL ) 3/27/2024 2:43:00 AM
Gainey McKenna & Egleston Announces A Second Class Action Lawsuit Has Been Filed Against Agilon Health, Inc. ( AGL ) - Agilon Health ( NYSE:AGL ) 3/26/2024 5:09:00 PM
AGL Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in agilon health, inc. Class Action - Agilon Health ( NYSE:AGL ) 3/26/2024 3:06:00 AM
Investor Alert ( NYSE: AGL ) : Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the Firm - Agilon Health ( NYSE:AGL ) 3/25/2024 10:59:00 PM
AGILON HEALTH, INC. ( NYSE: AGL ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against agilon health, inc. - Agilon Health ( NYSE:AGL ) 3/25/2024 4:30:00 PM
New Strong Sell Stocks for March 25th 3/25/2024 9:27:00 AM
AGILON ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against agilon health, inc. and Encourages Investors to Contact the Firm - Agilon Health ( NYSE:AGL ) 3/25/2024 1:00:00 AM

Financial Details for AGL

Company Overview

Ticker AGL
Company Name Agilon Health Inc
Country USA
Description agilon health, inc. The company is headquartered in Long Beach, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Most Recent Quarter 12/31/2023
Next Earnings Date 5/7/2024

Stock Price History

Last Day Price 5.73
Last Day Price Updated 3/28/2024 12:13:27 PM EST
Last Day Volume 6,465,753
Average Daily Volume 5,056,370
52-Week High 28.99
52-Week Low 4.44
Last Price to 52 Week Low 29.05%

Valuation Measures

Trailing PE N/A
Industry PE 39.98
Sector PE 60.76
5-Year Average PE -37.87
Free Cash Flow Ratio 22.04
Industry Free Cash Flow Ratio 16.74
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 1.51
Total Cash Per Share 0.26
Book Value Per Share Most Recent Quarter 1.63
Price to Book Ratio 2.95
Industry Price to Book Ratio 5.79
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.47
Industry Price to Sales Ratio Twelve Trailing Months 1.98
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 409,542,000
Market Capitalization 2,346,675,660
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 1,195.00%
Annual Earnings Growth -146.45%
Reported EPS 12 Trailing Months -0.48
Reported EPS Past Year -0.49
Reported EPS Prior Year -0.26
Net Income Twelve Trailing Months -262,596,000
Net Income Past Year -262,596,000
Net Income Prior Year -106,553,000
Quarterly Revenue Growth YOY 53.10%
5-Year Revenue Growth 53.64%

Balance Sheet

Total Cash Most Recent Quarter 107,570,000
Total Cash Past Year 107,570,000
Total Cash Prior Year 908,971,000
Net Cash Position Most Recent Quarter 69,012,000
Net Cash Position Past Year 69,012,000
Long Term Debt Past Year 38,558,000
Long Term Debt Prior Year 43,750,000
Total Debt Most Recent Quarter 38,558,000
Equity to Debt Ratio Past Year 0.94
Equity to Debt Ratio Most Recent Quarter 0.94
Total Stockholder Equity Past Year 661,839,000
Total Stockholder Equity Prior Year 1,041,220,000
Total Stockholder Equity Most Recent Quarter 661,839,000

Options

Put/Call Ratio 0.50
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.41
MACD Signal -0.40
20-Day Bollinger Lower Band 2.47
20-Day Bollinger Middle Band 8.30
20-Day Bollinger Upper Band 14.14
Beta 0.49
RSI 30.00
50-Day SMA 15.11
200-Day SMA 0.00

System

Modified 3/27/2024 4:53:43 PM EST